Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Reekon Pharmaceutical is a China-based pharmaceutical manufacturer and marketer headquartered in Zhuhai, Guangdong. The company appears to focus on the R&D, production, and commercialization of established medicines and consumer-facing healthcare products rather than novel biotech assets. Public company-directory sources describe production lines for tablets, capsules, creams and APIs, with product concentration in dermatology, respiratory, rheumatic/orthopedic, and digestive-system categories. Its best-known product appears to be hydroquinone cream marketed under the Qianbai brand, alongside other commercial products such as acetylcysteine capsules and glipizide tablets. The business is best characterized as an active private pharmaceutical company with commercial-stage products and in-house manufacturing capability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Reekon Pharmaceutical.